These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32299389)

  • 1. Expanded access to viral load testing and use of second line regimens in Haiti: time trends from 2010-2017.
    Wang Y; Barnhart S; Francois K; Robin E; Kalou M; Perrin G; Hall L; Koama JB; Marinho E; Balan JG; Honoré JG; Puttkammer N
    BMC Infect Dis; 2020 Apr; 20(1):283. PubMed ID: 32299389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.
    Nicholas S; Poulet E; Wolters L; Wapling J; Rakesh A; Amoros I; Szumilin E; Gueguen M; Schramm B
    J Int AIDS Soc; 2019 Aug; 22(8):e25387. PubMed ID: 31441242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successes and challenges in optimizing the viral load cascade to improve antiretroviral therapy adherence and rationalize second-line switches in Swaziland.
    Etoori D; Ciglenecki I; Ndlangamandla M; Edwards CG; Jobanputra K; Pasipamire M; Maphalala G; Yang C; Zabsonre I; Kabore SM; Goiri J; Teck R; Kerschberger B
    J Int AIDS Soc; 2018 Oct; 21(10):e25194. PubMed ID: 30350392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The viral load monitoring cascade in a resource-limited setting: A prospective multicentre cohort study after introduction of routine viral load monitoring in rural Lesotho.
    Glass TR; Motaboli L; Nsakala B; Lerotholi M; Vanobberghen F; Amstutz A; Lejone TI; Muhairwe J; Klimkait T; Labhardt ND
    PLoS One; 2019; 14(8):e0220337. PubMed ID: 31461455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti.
    Jean Louis F; Buteau J; François K; Hulland E; Domerçant JW; Yang C; Boncy J; Burris R; Pelletier V; Wagar N; Deyde V; Lowrance DW; Charles M
    PLoS One; 2018; 13(1):e0192077. PubMed ID: 29381736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
    Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
    Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
    Kadima J; Patterson E; Mburu M; Blat C; Nyanduko M; Bukusi EA; Cohen C; Oyaro P; Abuogi L
    PLoS One; 2018; 13(11):e0200242. PubMed ID: 30412576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When patients fail UNAIDS' last 90 - the "failure cascade" beyond 90-90-90 in rural Lesotho, Southern Africa: a
    Labhardt ND; Ringera I; Lejone TI; Cheleboi M; Wagner S; Muhairwe J; Klimkait T
    J Int AIDS Soc; 2017 Jul; 20(1):21803. PubMed ID: 28777506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India.
    Khan S; Das M; Andries A; Deshpande A; Mansoor H; Saranchuk P; Isaakidis P
    Glob Health Action; 2014; 7():24861. PubMed ID: 25084835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy.
    Kerschberger B; Boulle AM; Kranzer K; Hilderbrand K; Schomaker M; Coetzee D; Goemaere E; Van Cutsem G
    J Int AIDS Soc; 2015; 18(1):20092. PubMed ID: 26403636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa.
    Zaniewski E; Dao Ostinelli CH; Chammartin F; Maxwell N; Davies MA; Euvrard J; van Dijk J; Bosomprah S; Phiri S; Tanser F; Sipambo N; Muhairwe J; Fatti G; Prozesky H; Wood R; Ford N; Fox MP; Egger M
    J Int AIDS Soc; 2020 Jul; 23(7):e25546. PubMed ID: 32640106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.
    Ssempijja V; Nakigozi G; Chang L; Gray R; Wawer M; Ndyanabo A; Kasule J; Serwadda D; Castelnuovo B; Hoog AV; Reynolds SJ
    BMC Infect Dis; 2017 Aug; 17(1):582. PubMed ID: 28830382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Suboptimal Pediatric HIV Viral Load Cascade: Multidistrict Cohort Study Among Children Taking Antiretroviral Therapy in Lesotho, Southern Africa.
    Muhairwe JA; Brown JA; Motaboli L; Nsakala BL; Lerotholi M; Amstutz A; Klimkait T; Glass TR; Labhardt ND
    Pediatr Infect Dis J; 2022 Mar; 41(3):e75-e80. PubMed ID: 34862344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive Predictive Value of the WHO Clinical and Immunologic Criteria to Predict Viral Load Failure among Adults on First, or Second-Line Antiretroviral Therapy in Kenya.
    Waruru A; Muttai H; Ng'ang'a L; Ackers M; Kim A; Miruka F; Erick O; Okonji J; Ayuaya T; Schwarcz S
    PLoS One; 2016; 11(7):e0158881. PubMed ID: 27383834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term virologic responses to antiretroviral therapy among HIV-positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: a longitudinal analysis.
    Kehoe K; Boulle A; Tsondai PR; Euvrard J; Davies MA; Cornell M
    J Int AIDS Soc; 2020 May; 23(5):e25476. PubMed ID: 32406983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-care viral load testing among adolescents and youth living with HIV in Haiti: a protocol for a randomised trial to evaluate implementation and effect.
    Reif LK; Belizaire ME; Seo G; Rouzier V; Severe P; Joseph JM; Joseph B; Apollon S; Abrams EJ; Arpadi SM; Elul B; Pape JW; McNairy ML; Fitzgerald DW; Kuhn L
    BMJ Open; 2020 Aug; 10(8):e036147. PubMed ID: 32868354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative survey.
    Musengimana G; Tuyishime E; Kiromera A; Malamba SS; Mulindabigwi A; Habimana MR; Baribwira C; Ribakare M; Habimana SD; DeVos J; Mwesigwa RCN; Kayirangwa E; Semuhore JM; Rwibasira GN; Suthar AB; Remera E
    Antivir Ther; 2022 Jun; 27(3):13596535221102690. PubMed ID: 35593031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
    Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
    Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotyping and outcomes of presumptive second line ART failure cases switched to third line or maintained on second line ART in Mumbai, India.
    Gill N; Van den Bergh R; Wut Yee Kyaw K; Laxmeshwar C; Das M; Rastogi S; Arago Galindo M; Mansoor H; Kalon S; Isaakidis P
    PLoS One; 2019; 14(11):e0225631. PubMed ID: 31751433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for delayed viral suppression on first-line antiretroviral therapy among persons living with HIV in Haiti, 2013-2017.
    Rich SN; Cook RL; Yaghjyan L; Francois K; Puttkammer N; Robin E; Bae J; Joseph N; Pessoa-Brandão L; Delcher C
    PLoS One; 2020; 15(10):e0240817. PubMed ID: 33119631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.